Sun Pharma said it has received FDA approval for their hyperactivity disorder drug.

Sun Pharma said it has received FDA approval for their hyperactivity disorder drug.

Healthcare providers feel that the Mediclaim dispute requires joint solution in India.

Pyng Medical Corp has received 510(k) clearance from the U.S. FDA for their FASTx(TM) Sternal Intraosseous Device.

Fortis Healthcare plans to launch an IPO for its diagnostics business called Super Religare Laboratories in 2011.

Sun Pharma: Gets FDA approval for new drug
Sun Pharma: Gets FDA approval for new drug
Healthcare providers dispute over Mediclaim solution
Pyng Medical Corp: Gets FDA approval
Fortis Healthcare: Will open IPO in 2011

Follow us